Cigna Corp. will not cover Mylan’s EpiPen epinephrine autoinjector in 2017.

Instead, the insurer will cover Mylan’s $300 generic version of the EpiPen, which is half the list price of the brand-name drug. Cigna’s switch to the recently launched Mylan generic comes a day after President-elect Trump said many drug companies are “getting away with murder” setting their products’ prices. CVS Health reported that it would sell the authorized generic version of Adrenaclick, a less-prescribed alternative to the EpiPen. CVS will sell the generic version of Adrenaclick for $109.99 per twopack for both insured and uninsured patients—about onefifth the list price of the brandname EpiPen.